SMA OneTouch ICS - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SMA OneTouch ICS

The SMA OneTouch ICS is a computerized and automated viable monitoring system that controls precise and calibrated air sampling to individual or multiple SMA Atriums.   SMA Atriums are stainless steel collection devices that direct air from the environment to impact onto a nutrient agar plate. The nutrient agar plate is then evaluated to determine the amount of viable contamination in the air sample.

The SMA OneTouch ICS maintains strict regulation of the air flow during the sample cycle.  The system will automatically alarm the operator visually and audibly if the sample is compromised, aborted or completed.  In addition, the system continuously monitors the air-flow rate while sampling and will alert the operator if the air-flow deviates from the established 1 CFM flow rate of the system.

The SMA OneTouch ICS includes a touchscreen interface that incorporates facility floor plans, which provides the operator with ability to graphically select and monitor each individual SMA Atrium and helps to eliminate sampling errors.  The operator has the ability to automatically control sampling locations either simultaneously or independently.

VAI also offers the SMA OneTouch ICS for Isolators. This configuration includes all the aforementioned benefits and provides secure sampling inside the isolator environment.

Veltek Associates, Inc.
www.sterile.com
vai@sterile.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
FindPharma Custom Search

Click here